These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28866221)

  • 21. Immediate drug release from solid oral dosage forms.
    Schreiner T; Schaefer UF; Loth H
    J Pharm Sci; 2005 Jan; 94(1):120-33. PubMed ID: 15761936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review of Disintegration Mechanisms and Measurement Techniques.
    Markl D; Zeitler JA
    Pharm Res; 2017 May; 34(5):890-917. PubMed ID: 28251425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
    Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saturated phosphatidylcholine as matrix former for oral extended release dosage forms.
    Kolbina M; Bodmeier R; Körber M
    Eur J Pharm Sci; 2017 Oct; 108():86-92. PubMed ID: 28716757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of polyethylene glycol and polyoxyethylene stearate as excipients for solid dispersion systems of griseofulvin and tolbutamide II: dissolution and solubility studies.
    Kaur R; Grant DJ; Eaves T
    J Pharm Sci; 1980 Nov; 69(11):1321-6. PubMed ID: 7452464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated ketoprofen release from spray-dried polymeric particles: importance of phase transitions and excipient distribution.
    Gue E; Muschert S; Willart JF; Danede F; Delcourt-Debruyne E; Descamps M; Siepmann J
    Drug Dev Ind Pharm; 2015 May; 41(5):838-50. PubMed ID: 24766587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the drug/excipient particle size ratio in the percolation model for tablets.
    Millán M; Caraballo I; Rabasco AM
    Pharm Res; 1998 Feb; 15(2):216-20. PubMed ID: 9523306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous production of controlled release dosage forms based on hot-melt extruded gum arabic: Formulation development, in vitro characterization and evaluation of potential application fields.
    Kipping T; Rein H
    Int J Pharm; 2016 Jan; 497(1-2):36-53. PubMed ID: 26617317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modular solid dosage form design - Application to pH-independent release of a weak-base API.
    Cano-Vega MA; Deng M; Pinal R
    Int J Pharm; 2021 May; 601():120518. PubMed ID: 33775729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.